Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f1c5fca586aa60bf720d13d02f823f72 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fdaa64756184e715af6cb25ebc318917 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_dc349326fd37fecd48df2ce7c0d1c32e |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-14 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4702 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-713 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113 |
filingDate |
2007-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4782fe3d10c735cdf10f726107a6db9f http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_280c22c5d4bc2b1d079b975206fcdc41 |
publicationDate |
2008-03-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2008029414-A2 |
titleOfInvention |
Use of transcription factor inhibitor in the manufacture of a medicament |
abstract |
The invention relates to C/EBPbeta inhibitors and modulation of cell resistance or sensitivity to triggers of cell death. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2016208001-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2019063792-A3 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2022129071-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11781136-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014154898-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2016113357-A1 |
priorityDate |
2006-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |